Drugs News and Research

RSS

Study identifies substance released by pancreatic cancer cells to disarm attacking macrophages

A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.

21 Nov 2017

KNAUER celebrates 55th anniversary and awards science prize

Anniversary celebrations are often the occasion for a retrospective of successes and achievements. This is also the case with KNAUER Wissenschaftliche Geräte GmbH, founded in 1962.

From KNAUER Wissenschaftliche Geräte GmbH 21 Nov 2017

Probing living cells with AFM

An interview with Prof. David Alsteens, Université Catholique de Louvain conducted by April Cashin-Garbutt, MA (Cantab).

From Bruker Nano Surfaces and Metrology 21 Nov 2017

Study: Non-vitamin K antagonist oral anticoagulants linked to reduced kidney risks

Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.

20 Nov 2017

Preclinical study shows clear path toward effective treatment for rare bone disease

Researchers at Sanford Burnham Prebys Medical Discovery Institute have led a preclinical study demonstrating that the drug palovarotene suppresses the formation of bony tumors (osteochondromas) in models of multiple hereditary exostoses (MHE).

20 Nov 2017

ESMO Consortium Study advocates for equal access to quality cancer treatment across Asia

The European Society for Medical Oncology opened its 3rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia.

20 Nov 2017

Gold nanoparticles could potentially help in more effective drug delivery

Gold nanoparticles could help make drugs act more quickly and effectively, according to new research conducted at Binghamton University, State University of New York.

20 Nov 2017

New technique holds promise to screen cancer cells for drug susceptibility

Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to months of treatment with a drug that isn't working.

20 Nov 2017

Cancer drugs may offer new way to control high blood pressure

Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.

20 Nov 2017

FDA raids Florida stores that consumers use to buy drugs from Canada

The Food and Drug Administration last month sent criminal investigation agents with search warrants into nine storefronts across Central Florida that help customers order drugs from pharmacies in Canada and overseas at big discounts.

20 Nov 2017

KAIST researchers identify principles of gene network for colon tumorigenesis

The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.

20 Nov 2017

Benzodiazepines linked to increased risk of death among Alzheimer’s disease patients

Benzodiazepine and related drug use is associated with a 40 per cent increase in mortality among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The findings were published in the International Journal of Geriatric Psychiatry.

20 Nov 2017

FDA approves remote programming feature for Nucleus Cochlear Implant System via telemedicine

The U.S. Food and Drug Administration today approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.

20 Nov 2017

Researchers find way to switch tumor cells between 2D and 3D morphology

Paving the way for testing experimental drugs in more realistic environments, scientists at the National Institute of Standards and Technology have discovered how to make tiny colonies of cells grow in useful new ways inside petri dishes.

17 Nov 2017

Drug used to prevent and treat malaria may also be effective for Zika virus

A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective for Zika virus.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

Philips announces launch of global movement to raise awareness for COPD

Ahead of World COPD Day on November 15, Royal Philips, a leader in health technology, today announced the launch of a global movement to raise awareness for chronic obstructive pulmonary disease (COPD).

From Philips Healthcare 17 Nov 2017

New model to test effectiveness of existing and potential CF therapies

UNC School of Medicine researchers have developed a new laboratory model of the infection- and inflammation-plagued airways of cystic fibrosis (CF) patients.

17 Nov 2017

Research suggests new ways to mitigate impact of mistreatment at early age

Everyone has challenges of one kind or another. But research shows that mistreatment at an early age can have long-lasting and life-altering repercussions that could be passed to future generations.

17 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017